Intranasal Third-Generation CGRP Effective for Acute Migraine
Intranasal zavegepant, a third-generation calcitonin gene-related peptide (CGRP) receptor agonist, is effective and well tolerated in the treatment of acute
Read more
Intranasal zavegepant, a third-generation calcitonin gene-related peptide (CGRP) receptor agonist, is effective and well tolerated in the treatment of acute
Read moreAfter more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support
Read moreAfter more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Moderna completed manufacturing a version of
Read moreThe active ingredients in sunscreen may soak all the way into the user’s bloodstream, according to the results of a
Read more